brentuximab

navigate by keyword : brentuximab vedotin antibodydrug conjugate molecule consists monoclonal antibody conjugated molecules monomethyl adc cd30 hodgkin lymphoma anaplastic cathepsin auristatin mmae tumor cancer citrulline valine atoms atomic molecular compound composition chemical chemistry structure formula line drawing skeletal flat icon vector

Monomethyl auristatin E MMAE, vedotin, the cytotoxic payload of brentuximab vedotin antibody-drug conjugate. Skeletal formula. Royalty Free Stock Photo
Monomethyl auristatin E MMAE, vedotin, the cytotoxic payload of brentuximab vedotin antibody-drug conjugate. Skeletal formula. Royalty Free Stock Photo
Brentuximab vedotin antibody-drug conjugate molecule. Consists of monoclonal antibody conjugated to 3-5 molecules of monomethyl. Royalty Free Stock Photo
Bone marrow infiltrated by Hodgkin lymphoma Royalty Free Stock Photo
Bone marrow infiltrated by Hodgkin lymphoma Royalty Free Stock Photo
   
   
Brentuximab vedotin antibody-drug conjugate molecule. Consists of monoclonal antibody conjugated to 3-5 molecules of monomethyl.
Bone marrow infiltrated by Hodgkin lymphoma Royalty Free Stock Photo
Anaplastic large-cell lymphoma. Peripheral blood. Royalty Free Stock Photo
   
   
Anaplastic large-cell lymphoma. Peripheral blood. Royalty Free Stock Photo
Anaplastic large-cell lymphoma. Peripheral blood. Royalty Free Stock Photo
Anaplastic large-cell lymphoma. Peripheral blood. Royalty Free Stock Photo
Brentuximab vedotin antibody-drug conjugate molecule. Consists of monoclonal antibody conjugated to 3-5 molecules of monomethyl auristatin E. Skeletal formula


Stockphotos.ro (c) 2025. All stock photos are provided by Dreamstime and are copyrighted by their respective owners.